Halozyme Therapeutics Inc (HALO)
46.93
-0.39
(-0.82%)
USD |
NASDAQ |
Dec 20, 16:00
46.95
+0.02
(+0.04%)
After-Hours: 20:00
Halozyme Therapeutics Shareholders Equity (Quarterly): 452.70M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | 178.51M |
| Novavax Inc | -526.44M |
| Kura Oncology Inc | 423.77M |
| TransMedics Group Inc | 209.92M |
| Pulmonx Corp | 93.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.118B |
| Total Liabilities (Quarterly) | 1.665B |
| Debt to Equity Ratio | 3.323 |
| Current Ratio | 10.36 |
| Net Debt Paydown Yield | -0.02% |